Ayala Pharmaceuticals Inc (ADXS)

[equaloppforall]

Phyto, it makes zero sense when people deny short manipulation. The evidence is all there right in front of their eyes but they refuse to acknowledge it.

Now I've always agreed that ADXS has made certain missteps in communication and in not striking enough accretive deals. But the shorts and their spokespeople admit to no reasonable argument. If ADXS were trading at cash value, as it almost is, they still argue that it is trading $2 too high.

I'll leave it everyone's judgment to conclude who makes sense here.